AION Biosystems has announced a significant advancement in cancer care with TempShield™, an AI-powered wearable thermometer that has demonstrated a 90% reduction in mortality and a 79% decrease in inpatient days for chemotherapy patients. These findings, revealed at the 2025 ASCO Annual Meeting, represent the first validated long-term temperature monitoring in outpatient oncology, promising earlier infection detection and improved patient outcomes. Read More